The ibs.GRANADA successfully holds the XNUMXst Symposium on advances in advanced therapies and biosanitary technologies
The Biosanitary Research Institute of Granada (ibs.GRANADA) has organized this Tuesday a conference that addresses the latest advances in research in advanced therapies and biosanitary technologies. This meeting, promoted by the Area of Advanced Therapies and Health Technologies of the ibs.GRANADA, whose leaders are Dr. Cristina Lucía Dávila Fajardo and Dr. Miguel Alaminos Mingorance Gómez, aims to present the lines of work focused on this field carried out carried out by the research groups of the Granada institute, which includes groups from the Virgen de las Nieves University Hospital, the San Cecilio University Hospital, the University of Granada and the Andalusian School of Public Health.
The Conference was opened by the territorial delegate for Health and Families, Indalecio Sánchez Montesinos, and the dean of the Faculty of Medicine of the University of Granada, Aurora Valenzuela; the managing director of the Virgen de las Nieves University Hospital, José Francisco Guerrero; the deputy director of the San Cecilio de Granada University Hospital, Mr. Manuel Reyes Nadal, the managing director of ibs.GRANADA and FIBAO, the scientific vice director of ibs.GRANADA, María José Sánchez; and the director of scientific policy of the Vice President for Research and Transfer of the University of Granada, Pedro A. Castillo.
Scientists from all the institutions that make up the ibs.GRANADA have participated in this scientific meeting. In it, a multidisciplinary and comprehensive approach to advanced therapies and the latest biosanitary technologies has been carried out, with sessions distributed in three discussion tables that have dealt with advances in new biomedical technologies, the generation of new pharmacological treatments and personalized medicine (pharmacogenetics), and the dissemination and transfer of research results in advanced therapies.
This meeting, in which more than fifty scientists have attended, has constituted an opportunity of the first magnitude to learn about the different scientific projects in advanced therapies and biosanitary technologies that are developed by the ibs.GRANADA research groups of excellence.
